Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 3/20 | 0.49 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.49 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.49 |
| ▸ | RELA | Q04206 | 1/20 | 0.49 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.41 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.41 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.40 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.39 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.39 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | THRA | P10827 | 1/20 | 0.37 |
| ▸ | THRB | P10828 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | IDO1 | P14902 | 1/20 | 0.36 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12894651 | 0.88 | GAA (0.52) | ALOX5NFKB1NFKB2RELAGAA | |
| SCHEMBL9971674 | 0.85 | CYP4F2 (0.49) | ALOX5NFKB1NFKB2RELAGABRA1 | |
| SCHEMBL10015715 | 0.84 | ALOX5 (0.44) | ALOX5NFKB1NFKB2RELAGABRA1 | |
| SCHEMBL8751252 | 0.82 | ALOX5 (0.40) | ALOX5NFKB1NFKB2RELAGABRA1 | |
| SCHEMBL8137555 | 0.82 | ALOX5 (0.43) | ALOX5NFKB1NFKB2RELAGABRA1 | |
| SCHEMBL815527 | 0.82 | GABRA1 (0.44) | ALOX5NFKB1NFKB2RELAGABRA1 | |
| SCHEMBL17260612 | 0.82 | THRA (0.49) | ALOX5NFKB1NFKB2RELAGABRA1 | |
| SCHEMBL8767270 | 0.81 | GABRA1 (0.43) | ALOX5NFKB1NFKB2RELAGABRA1 | |
| SCHEMBL20138113 | 0.80 | TDP1 (0.40) | ALOX5NFKB1NFKB2RELAGABRA1 | |
| SCHEMBL26229210 | 0.80 | ALOX5 (0.43) | ALOX5NFKB1NFKB2RELAGABRA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3143086-A1 | STABILISED RESIN COMPOSITION | SABIC Global Technologies B.V. (NL) | 2017-03-22 | — | — | EP | claimed |
| WO-2015173315-A1 | STABILISED RESIN COMPOSITION | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2015-11-19 | — | — | WO | claimed |
| EP-3143086-A1 | STABILISED RESIN COMPOSITION | SABIC Global Technologies B.V. (NL) | 2017-03-22 | — | — | EP | disclosed |
| WO-2015173315-A1 | STABILISED RESIN COMPOSITION | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2015-11-19 | — | — | WO | disclosed |
| US-20120245260-A1 | Polyolefin Composition for Membranes | Basell Poliolefine Italia, s.r.l. (IT) | 2012-09-27 | — | — | US | disclosed |
| US-20110054220-A1 | POLYETHER POLYOLS, POLYESTER POLYOLS AND POLYURETHANES OF LOW RESIDUAL ALDEHYDE CONTENT | GOH CHIN SIONG | 2011-03-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110054220-A1 | POLYETHER POLYOLS, POLYESTER POLYOLS AND POLYURETHANES OF LOW RESIDUAL ALDEHYDE CONTENT | PUF60, GPX4, AOX1 | ALOX5 123/4885NFKB1 3862/4885NFKB2 2405/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.